The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

“(Friday’s) decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

With major changes coming to the Federal Employee Health Benefits (FEHB) plan, employees and retirees need to pay extra ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Anatara Lifesciences Ltd (AU:ANR) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...